ARS Pharmaceuticals had a revenue of 28.09M in the quarter ending Dec 31, 2025, with -13.58%. This bring the company's revenue in the last twelve months to 84.28M, Increased -40.97%. In the fiscal year ending Dec 31, 2024, ARS Pharmaceuticals had annual revenue of 89.15M with 297063.33% growth.